Recent clinical research indicates that semaglutide may effectively reverse weight gain and blood sugar issues caused by ...
Schizophrenia spectrum disorders significantly increase cardiovascular and metabolic disease risks, partly due to antipsychotic-induced weight gain and glucose dysregulation.
Clozapine (CLZ) is a "gold standard" drug for managing treatment-resistant schizophrenia (TRS), who do not respond adequately to first-line antipsychotics. Despite its efficacy with TRS, the use of ...
Clozapine 12.5mg, 25mg, 100mg, 150mg, 200mg; contains phenylalanine. Caution with drugs that affect or are affected by CYPA1A2, 2D6, 3A4. Concomitant strong CYP1A2 ...
MedPage Today on MSN
Ozempic Improves Glycemic Control, Cuts Weight in Schizophrenia Patients
Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...
A woman on clozapine develops severe gastrointestinal hypomotility that progresses to toxic megacolon and multiorgan failure, ...
For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant schizophrenia, and the only one it recognizes as reducing the risk of suicide. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback